Lesotho vs Mus: Estimated antiretroviral therapy coverage among people living with HIV
Lesotho
96.0%
in 2025
Mus
36.0%
in 2025
Lesotho rank
4th
Mus rank
2nd
Estimated antiretroviral therapy coverage among people living with HIV over time
- Lesotho
- Mus
How they compare
Lesotho currently reports 96.0% against 36.0% in Mus, a difference of 60.0%.
That makes Lesotho's figure about 2.7 times Mus's.
The two have swapped places 1 time across 26 shared years of data; in 2000 it was Mus ahead.
Lesotho ranks 4th and Mus ranks 2nd of 143 countries.
Lesotho has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Lesotho | Mus | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 7.3% | 2.9% | 4.4% | Lesotho |
| 2010s | 51.6% | 20.5% | 31.1% | Lesotho |
| 2020s | 89.2% | 30.7% | 58.5% | Lesotho |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher estimated antiretroviral therapy coverage among people living with hiv, Lesotho or Mus?
- Lesotho, at 96.0% against 36.0% in Mus as of 2025.
- What is the difference in estimated antiretroviral therapy coverage among people living with hiv between Lesotho and Mus?
- 60.0%, with Lesotho ahead.
- How many years of comparable data are there for Lesotho and Mus?
- 26 years are reported by both, from 2000 to 2025.
- How do Lesotho and Mus rank globally for estimated antiretroviral therapy coverage among people living with hiv?
- Lesotho ranks 4th and Mus ranks 2nd of 143 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.